{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:22:13Z","timestamp":1787862133794,"version":"build-2784847793"},"reference-count":38,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016148","name":"Korean Liver Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016148","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016147","name":"Korean Association for the Study of the Liver","doi-asserted-by":"publisher","award":["KASLKLF2023-04"],"award-info":[{"award-number":["KASLKLF2023-04"]}],"id":[{"id":"10.13039\/501100016147","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jiph.2026.103331","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T06:42:27Z","timestamp":1786084947000},"page":"103331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimizing hepatitis C micro-elimination in forensic psychiatric settings: Cost-effectiveness of screening strategies in Korea"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8048-0670","authenticated-orcid":false,"given":"Gyeongseon","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hoon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7780-159X","authenticated-orcid":false,"given":"Hankil","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5363-2496","authenticated-orcid":false,"given":"Beom Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2026.103331_bib1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jiph.2026.103331_bib2","article-title":"Global mortality of chronic liver diseases attributable to Hepatitis B virus and Hepatitis C virus infections from 1990 to 2019 and projections to 2030","volume":"17","author":"Nguyen","year":"2024","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jiph.2026.103331_bib3","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.3350\/cmh.2024.0262","article-title":"Non-invasive prediction of post-sustained virological response hepatocellular carcinoma in hepatitis C virus: a systematic review and meta-analysis","volume":"30","author":"Lee","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jiph.2026.103331_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3350\/cmh.2024.0795","volume":"31","author":"Chun","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jiph.2026.103331_bib5","doi-asserted-by":"crossref","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","article-title":"Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review","volume":"5","author":"Degenhardt","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jiph.2026.103331_bib6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jiph.2014.07.018","article-title":"Prevalence and correlates of hepatitis C virus infection among inmates at two New York State correctional facilities","volume":"7","author":"Alvarez","year":"2014","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jiph.2026.103331_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/liv.14363","article-title":"Micro-elimination of hepatitis C virus","volume":"40","author":"Hollande","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jiph.2026.103331_bib8","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.3748\/wjg.v27.i16.1728","article-title":"Hepatitis C virus micro-elimination: where do we stand?","volume":"27","author":"Mangia","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jiph.2026.103331_bib9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3350\/cmh.2024.0557","article-title":"Elimination of viral hepatitis: How far are we?: Editorial on \u201cCore indicators related to the elimination of hepatitis B and C virus infection in South Korea: a nationwide study","volume":"30","author":"Cho","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jiph.2026.103331_bib10","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3350\/cmh.2023.0110","article-title":"Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: a nationwide study","volume":"29","author":"Lee","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jiph.2026.103331_bib11","unstructured":"Choi G.H., Chon Y.-H., Kwon D.H., Jo S.N., Jang O.-J., Kim K.-A., et al. Prevalence, Clinical Characteristics, and Treatment Status of Hepatitis C Virus Infection among People Who Use Drugs in South Korea: A Prospective Multicenter Study. Gut Liver."},{"key":"10.1016\/j.jiph.2026.103331_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/JFN.0000000000000492","article-title":"Factors influencing the personal recovery of inpatients in a forensic psychiatric hospital in South Korea","volume":"21","author":"Gang","year":"2025","journal-title":"J Forensic Nurs"},{"key":"10.1016\/j.jiph.2026.103331_bib13","article-title":"Development and optimisation of a reception testing protocol designed to eliminate HCV in the UK prison population","volume":"6","author":"Mongale","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jiph.2026.103331_bib14","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1093\/cid\/ciz088","article-title":"Modelling the impact and cost-effectiveness of extended hepatitis C virus screening and treatment with direct-acting antivirals in a Swiss custodial setting","volume":"69","author":"Girardin","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2026.103331_bib15","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1111\/liv.14628","article-title":"Cost-effectiveness of strategies to improve HCV screening, linkage-to-care and treatment in remand prison settings in England","volume":"40","author":"Mohamed","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jiph.2026.103331_bib16","series-title":"Pilot study of screening and treatment linkage for high-risk groups of viral hepatitis","author":"Choe","year":"2024"},{"key":"10.1016\/j.jiph.2026.103331_bib17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.7326\/M15-0617","article-title":"Prevention of hepatitis C by screening and treatment in US prisons","volume":"164","author":"He","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiph.2026.103331_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245896","article-title":"Hepatitis C treatment strategies in prisons: a cost-effectiveness analysis","volume":"16","author":"Kwon","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jiph.2026.103331_bib19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3350\/cmh.2024.0484","article-title":"Self-testing strategy to eliminate hepatitis C as per World Health Organization\u2019s goal: analysis of disease burden and cost-effectiveness","volume":"31","author":"Shin","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jiph.2026.103331_bib20","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1111\/liv.15705","article-title":"Determining reinfection rates by hepatitis C testing interval among key populations: a systematic review and meta-analysis","volume":"43","author":"Munari","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.jiph.2026.103331_bib21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2468-1253(19)30085-8","article-title":"The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study","volume":"4","author":"Trickey","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jiph.2026.103331_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-7517-10-7","article-title":"Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors","volume":"10","author":"Harris","year":"2013","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.jiph.2026.103331_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jsat.2019.01.021","article-title":"Barriers and facilitators of hepatitis C treatment uptake among people who inject drugs enrolled in opioid treatment programs in Baltimore","volume":"100","author":"Falade-Nwulia","year":"2019","journal-title":"J Subst Abus Treat"},{"key":"10.1016\/j.jiph.2026.103331_bib24","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1111\/liv.14634","article-title":"Hepatitis C treatment uptake among people who inject drugs in the oral direct-acting antiviral era","volume":"40","author":"Falade-Nwulia","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jiph.2026.103331_bib25","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2023.38.e357","article-title":"Hepatitis C Virus Seroprevalence in persons who inject drugs in Korea, 2012\u20132022: a multicenter, retrospective study","volume":"38","author":"Kim","year":"2023","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jiph.2026.103331_bib26","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jiph.2023.05.019","article-title":"A new collaborative care approach toward hepatitis C elimination in marginalized populations","volume":"16","author":"Su","year":"2023","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jiph.2026.103331_bib27","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/cid\/ciz383","article-title":"Cost-effectiveness and budgetary impact of hepatitis C virus testing, treatment, and linkage to care in US prisons","volume":"70","author":"Assoumou","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2026.103331_bib28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.18176\/resp.00012","article-title":"Cost-effectiveness analysis of chronic hepatitis C treatment in the prison population in Spain","volume":"22","author":"Marco","year":"2020","journal-title":"Rev Esp Sanid Penit"},{"key":"10.1016\/j.jiph.2026.103331_bib29","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/hep.28497","article-title":"Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysis","volume":"63","author":"Martin","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jiph.2026.103331_bib30","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1111\/add.16305","article-title":"Cost-effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: an economic evaluation of the INTRO-HCV trial","volume":"118","author":"Lim","year":"2023","journal-title":"Addiction"},{"key":"10.1016\/j.jiph.2026.103331_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2019.102608","article-title":"Time matters: point of care screening and streamlined linkage to care dramatically improves hepatitis C treatment uptake in prisoners in England","volume":"75","author":"Mohamed","year":"2020","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.jiph.2026.103331_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103394","article-title":"Cost-effectiveness of mass screening for hepatitis C virus among all inmates in an Irish prison","volume":"96","author":"Ward","year":"2021","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.jiph.2026.103331_bib33","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1093\/cid\/cit296","article-title":"Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy","volume":"57","author":"Martin","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2026.103331_bib34","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12954-018-0269-z","article-title":"Barriers and facilitators to hepatitis C (HCV) screening and treatment\u2014a description of prisoners\u2019 perspective","volume":"15","author":"Crowley","year":"2018","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.jiph.2026.103331_bib35","article-title":"Contemporary awareness of viral hepatitis between 2012 and 2022 among Korean adults","volume":"31","author":"Kim","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jiph.2026.103331_bib36","article-title":"Correspondence to letter to the editor on \u201cContemporary awareness of viral hepatitis between 2012 and 2022 among Korean adults\u201d","volume":"31","author":"Lee","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jiph.2026.103331_bib37","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3390\/ijerph22020238","article-title":"'You\u2019ve Just Got to Keep Pestering\u2019: barriers and enablers of attaining continuity of hepatitis C care for people transitioning between prison and community health services in South-East Queensland, Australia","volume":"22","author":"Panahi","year":"2025","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jiph.2026.103331_bib38","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3350\/cmh.2024.0630","volume":"31","author":"Hui","year":"2024","journal-title":"Clin Mol Hepatol"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034126002030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034126002030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T19:48:32Z","timestamp":1787860112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034126002030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1876034126002030"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2026.103331","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing hepatitis C micro-elimination in forensic psychiatric settings: Cost-effectiveness of screening strategies in Korea","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2026.103331","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"103331"}}